|
US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
|
US20060270639A1
(en)
*
|
1997-06-20 |
2006-11-30 |
Daniela Salvemini |
Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
|
|
US20050171198A1
(en)
*
|
1997-06-20 |
2005-08-04 |
Metaphore Pharmaceuticals, Inc. |
SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
|
|
US6214817B1
(en)
*
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
CA2309154C
(en)
|
1997-11-03 |
2010-02-16 |
Duke University |
Substituted porphyrins
|
|
ATE552260T1
(de)
*
|
1999-01-25 |
2012-04-15 |
Nat Jewish Health |
Substituierte porphyrine und deren therapeutische verwendung
|
|
AU5048400A
(en)
|
1999-05-27 |
2000-12-18 |
Monsanto Company |
Biomaterials modified with superoxide dismutase mimics
|
|
US20030069281A1
(en)
*
|
2000-06-14 |
2003-04-10 |
Irwin Fridovich |
Tetrapyrroles
|
|
US20020072512A1
(en)
*
|
2000-12-08 |
2002-06-13 |
Metaphore Pharmaceuticals, Inc |
Method of preventing and treating HIV-mediated central nervous system damage
|
|
US20050175580A1
(en)
*
|
2001-01-05 |
2005-08-11 |
Daniela Salvemini |
Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
|
|
ATE439134T1
(de)
*
|
2001-01-19 |
2009-08-15 |
Nat Jewish Med & Res Center |
Medikament zum schutz in der radiotherapie
|
|
WO2002058686A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Metaphore Pharmaceuticals, Inc. |
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
|
|
EP1405066B1
(en)
*
|
2001-03-02 |
2015-06-17 |
Galera Therapeutics LLC |
Chromatography of metal complexes
|
|
US20040137638A1
(en)
*
|
2002-03-04 |
2004-07-15 |
Slomczynska Urszula J. |
Chromatography of metal complexes
|
|
AU2002312194B8
(en)
*
|
2001-06-01 |
2008-05-15 |
Aeolus Sciences, Inc. |
Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
|
|
AU2002315001A1
(en)
*
|
2001-06-08 |
2002-12-23 |
Metaphore Pharmaceuticals, Inc. |
Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
|
|
JP2005519852A
(ja)
*
|
2001-06-26 |
2005-07-07 |
メタファー・ファーマシューティカルズ・インコーポレイテッド |
炎症性疾患の予防および／または処置のためのＳＯＤｍとコルチコステロイドの組合せ療養
|
|
WO2003039561A1
(en)
*
|
2001-11-02 |
2003-05-15 |
Elan Corporation, Plc |
Pharmaceutical composition
|
|
PT1463563E
(pt)
*
|
2001-12-14 |
2009-03-19 |
Alcon Inc |
Miméticos de dismutase do superóxido para o tratamento de distúrbios e doenças oculares
|
|
US6933275B2
(en)
*
|
2002-05-01 |
2005-08-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protein kinase C peptides for use in withdrawal
|
|
EP1513537A4
(en)
*
|
2002-06-07 |
2006-09-06 |
Univ Duke |
Substituted porphyrins
|
|
US20030232784A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Benedict James J. |
Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
|
|
CA2397684A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Michael P. Murphy |
Mitochondrially targeted antioxidants
|
|
CA2499994C
(en)
*
|
2002-09-23 |
2012-07-10 |
Verion, Inc. |
Abuse-resistant pharmaceutical compositions
|
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
|
CN1717234A
(zh)
*
|
2002-12-06 |
2006-01-04 |
爱尔康公司 |
用于治疗眼紊乱和疾病的超氧化物岐化酶模拟物
|
|
KR100648618B1
(ko)
*
|
2003-11-19 |
2006-11-23 |
주식회사 웰스킨 |
활성 산소 억제제
|
|
KR20060101501A
(ko)
*
|
2003-12-11 |
2006-09-25 |
알콘, 인코퍼레이티드 |
시신경 및 망막 손상의 치료를 위한 슈퍼옥사이드디스무타제 유사체
|
|
US20120301403A1
(en)
|
2007-06-21 |
2012-11-29 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
US8217166B2
(en)
*
|
2005-05-05 |
2012-07-10 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
WO2006069326A2
(en)
*
|
2004-12-21 |
2006-06-29 |
Metaphore Pharmaceuticals, Inc. |
Polyethylene glycolated superoxide dismutase mimetics
|
|
KR100724586B1
(ko)
|
2005-12-09 |
2007-06-04 |
세종대학교산학협력단 |
수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물
|
|
EP2056675B1
(en)
*
|
2006-10-12 |
2019-01-09 |
Galera Labs, LLC |
Methods of treating oral mucositis
|
|
WO2009065059A2
(en)
|
2007-11-14 |
2009-05-22 |
Kereos, Inc. |
Super-oxide dismutase mimetics
|
|
ES2530462T3
(es)
|
2008-05-22 |
2015-03-03 |
Galera Therapeutics Llc |
Combinación terapia antitumoral
|
|
EP2732817B1
(en)
|
2008-05-23 |
2016-08-24 |
National Jewish Health |
A compound for use in treating injury associated with exposure to phosgene or chlorine gas
|
|
WO2013048965A1
(en)
|
2011-09-26 |
2013-04-04 |
Galera Therapeutics, Llc |
Methods for treatment of diseases
|
|
UA126788C2
(uk)
|
2015-08-11 |
2023-02-08 |
Ґалера Лебз, Елелсі |
Комплексні сполуки, що містять макроциклічне кільце пентаази, які мають пероральну біодоступність
|
|
US12220420B2
(en)
|
2016-05-03 |
2025-02-11 |
Galera Labs, Llc |
Combination therapy for cancer treatment
|
|
AU2017318718B2
(en)
|
2016-09-01 |
2023-06-29 |
Galera Labs, Llc |
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
|
|
CA3053779A1
(en)
|
2017-02-15 |
2018-08-23 |
Galera Labs, Llc |
Pentaaza macrocyclic ring complexes for local intestinal delivery
|
|
US11246950B2
(en)
|
2017-04-13 |
2022-02-15 |
Galera Labs, Llc |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
AU2019215032A1
(en)
|
2018-01-31 |
2020-09-10 |
Board Of Regents Of The University Of Texas System |
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
|
WO2021163397A1
(en)
|
2020-02-13 |
2021-08-19 |
Teva Pharmaceuticals International Gmbh |
Solid state forms of avasopasem manganese and process for preparation thereof
|
|
WO2025024390A2
(en)
*
|
2023-07-21 |
2025-01-30 |
Galera Labs, Llc |
Carcinogenesis reduction with pentaaza macrocyclic ring complex
|